Syngene concludes acquisition of biologics manufacturing facility from Emergent BioSolutions
The new site will increase Syngene's total single-use bioreactor capacity to 50,000L
The new site will increase Syngene's total single-use bioreactor capacity to 50,000L
Apitoria Pharma’s API manufacturing facility classified as VAI by USFDA
Previously, Sujatha has held leadership positions at prominent organizations, including Publicis Sapient, Infinite Computer Solutions, and Capgemini
FlexiTubes will showcase range of eco-friendly and innovative tube options
Apalutamide is an androgen receptor inhibitor indicated for the treatment of patients with metastatic castration-sensitive prostate cancer
This facility represents a significant step in Croda’s Pharma business strategy to ‘Empower biologics delivery’
Nipaguard SCE Vita delivers comprehensive antimicrobial protection for personal care formulations
Alkem Medtech to acquire 100% stake of Bombay Ortho
Amifampridine Tablets, 10 mg are indicated for the treatment of Lambert-Eaton myasthenic syndrome in adults and pediatric patients 6 years of age and older.
Subscribe To Our Newsletter & Stay Updated